Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Danlong
- Development stage
- Unknown
- Lead developer
- Zhejiang Kangde Pharmaceutical Group
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Danlong refers to two distinct Traditional Chinese Medicine (TCM) formulations used for different clinical indications. **Danlong Oral Liquid** (丹龙口服液), developed by Zhejiang Kangde Pharmaceutical Group, is an approved TCM in China for the treatment of bronchial asthma, specifically targeting 'heat asthma syndrome.' It is formulated with ingredients such as *Lumbricus* (Di Long), *Scutellaria baicalensis* (Huang Qin), and *Arisaema cum Bile* (Dan Nan Xing) to clear heat, resolve phlegm, and relieve wheezing. Research suggests it modulates the immune response by inhibiting Th2-mediated airway inflammation and reducing levels of inflammatory cytokines like IL-4 and IL-5. **Danlong Tablet** (丹龙片), developed by Sichuan Enwei Chinese Medicine, is a separate formulation containing *Salvia miltiorrhiza* (Dan Shen) and *Dracaena cochinchinensis* (Long Xue Jie), which has been investigated in clinical trials for the treatment of hyperplasia of the mammary gland.
- Brand names
- Danlong Oral LiquidDanlong Tablet
- Other names
- Danlong Oral LiquidDanlong Tablet
02
Targets
IL-4 (Interleukin 4)IL-5 (Interleukin 5)
Beyond the preview
Go deeper on Danlong.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Danlong.